DELTA MUTUAL, INC.
                             111 North Branch Street
                             Sellersville, PA 18960

                                January 27, 2006

Securities and Exchange Commission
Washington, D.C. 20549

Dear Sir/Madam:

      We have received your comment  letter dated January 6, 2006.  The response
letter of Delta  Mutual,  Inc.  (the  "Company")  to these  comments is attached
hereto.

      As  President  of the  Company,  this is to  confirm  that the  Company is
responsible  for the accuracy and adequacy of the  disclosure in the filings.  I
personally  review all filings  before they are  submitted and work closely with
the Company's legal counsel and auditor.

      I acknowledge  that staff comments or changes to disclosure in response to
staff  comments do not foreclose the  Securities  and Exchange  Commission  from
taking any action  with  respect to the  filings  and that the  Company  may not
assert staff comments as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United States.

      I am also  aware  that the  Division  of  Enforcement  has  access  to all
information  we provide to the staff of the Division of  Corporation  Finance in
your review of our filings or in response to your comments on our filings.

Sincerely,


/s/ Peter F. Russo

Peter F. Russo
President
Delta Mutual, Inc.


                               DELTA MUTUAL, INC.
                             111 North Branch Street
                             Sellersville, PA 18960

January 27, 2006

Mr. Jorge Bonilla
United States Securities and Exchange Commission
450 Fifth Street, N. W.
Washington, DC  20549

RE:   Delta Mutual, Inc.
      Form 10-KSB for the year ended December 31, 2004
      Forms 10-QSB for the quarters ended March 31, 2005 and June 30, 2005
      File No. 000-30563


Form 10-KSB

Balance Sheet, page F-2

SEC COMMENT #1: We have read and  considered  your  response to comment  one. We
noted  that  the  pre-acquisition  costs  of  $170K  is in  connection  with the
acquisition and proposed  development of approximately 270 low income homes that
are designated as Section 124 eligible in the city of Aguadilla, Puerto Rico. In
capitalizing  these  pre-acquisition  costs, tell us how you determined that the
acquisition  and development of the property was probable given the fact that on
June 28,  2005 and  September  2005 the  Planning  Board of Puerto  Rico did not
approve  the Section 124 project in  Aguadilla,  Puerto  Rico.  Refer to SFAS 67
paragraph 4 and 5.

COMPANY  RESPONSE:  For the year ended December 31, 2004, the Company  accounted
for  pre-acquisition  costs of $170K in  accordance  with  Financial  Accounting
Standards  Board  Statement  No.67  ("Accounting  for Costs and  Initial  Rented
Operations of Real Estate  Property").  As of December 31, 2004, the acquisition
and development of the property was probable based on the information available.
During 2005 the project was not approved by the  Planning  Board but was subject
to further review by an appellate  administrative  agency. As of the filing date
of the quarterly  report for the period ending  September 30, 2005,  the Company
believed the  acquisition  and development of the property was probable based on
the  additional  information  submitted  with its  administrative  appeal to the
Tribunal de Circuito de  Apelaciones  (Appellate  Tribunal) on October 21, 2005.
Prior to the filing of the  Company's  10-KSB for the year ending  December  31,
2005,  the Company will evaluate the facts and  circumstances  and determine the
probability of the proposed project.


Note 1 - Description of Business and Summary of Significant Accounting Policies

Evaluation of Long-Lived Assets, page F-11

SEC COMMENT #2: We have read and  considered  your  response to comment two. You
indicate in your letter that you test long-lived  assets for impairment based on
the  estimated  undiscounted  cash  flows.  However,  note 1  indicates  that an
impairment loss would be charged if the carrying value of the long-lived  assets
exceeds the present value of the related  estimated future cash flows. In future
filings,  please  indicate that, as we assume,  you test  long-lived  assets for
impairment based on the undiscounted  cash flows as oppose to the present value.
Advise us if you plan to expand your disclosure in future filings.

COMPANY RESPONSE:  In future filings the Company will test long-lived assets for
impairment based on the undiscounted cash flows as opposed to present value.

Note 5 - Investment in Joint Ventures, pages F-18 - F-19

SEC  COMMENT #3: We have read and  considered  your  response to comment  three.
Please explain to us how  Delta-Envirotech,  Inc. meets the definition of VIE in
paragraph 5 of FIN(R).  In addition,  please explain to us how you concluded you
were the primary beneficiary of this entity in accordance with paragraph 14.

COMPANY  RESPONSE:  Delta-Envirotech,  Inc.  meets  the  definition  of  VIE  in
accordance  with (a) in paragraph 5 of FIN(R).  The total equity  investment  at
risk is not  sufficient to permit the entity to finance its  activities  without
additional  subordinated  financial  support provided by any parties,  including
equity holders.

In accordance  with  paragraph 14, the Company is the primary  beneficiary as it
will absorb a majority of the entity's expected losses.

Note 6 - Convertible Debt, page F-19 - F-20

SEC COMMENT #4: We have read and  considered  your  response to comment four. We
noted that you determined the beneficial conversion feature to be the fair value
of the convertible  debt. Tell us how you considered EITF 00-27 as it stipulates
that the EITF 98-5  model  should be  applied  to the  amount  allocated  to the
convertible  instrument  to determine if the embedded  conversion  option has an
intrinsic value. EITF 98-5 defines intrinsic value as the difference between the
conversion  price and the fair  value of the stock into  which the  security  in
convertible,  multiplied  by the  number of shares  into which the  security  in
convertible.  Also,  disclose the amortization  period of the intrinsic value of
the  beneficial  conversion  feature  and refer us to the GAAP  literature  that
supports this policy.

COMPANY  RESPONSE:  In accordance  with EITF 00-27,  paragraph 5, the Task Force
reached a consensus  that the effective  conversion  price based on the proceeds
received  for or  allocated  to the  convertible  instrument  should  be used to
compute the intrinsic  value, if any, of the embedded  conversion  option.  As a
result of this consensus,  an issuer should first allocate the proceeds received
in a  financing  transaction  that  includes  a  convertible  instrument  to the
convertible  instrument  and any other  detachable  instruments  included in the
exchange (such as detachable warrants) on a relative fair value basis. Then, the
Issue 98-5 model should be applied to the amount  allocated  to the  convertible
instrument,  and an effective  conversion price should be calculated and used to
measure the intrinsic value, if any, of the embedded conversion option.


The Company  performed  the  calculations  of  allocating  the proceeds from the
issuance  of  convertible  debt  with  detachable  warrants  to each  respective
security  based upon their  relative fair values in  accordance  with Issue 98-5
model.  The Company  calculated  the  conversion  value for each  debenture  and
determined the excess conversion value versus the allocated proceeds.

Convertible  debt in the  amount  of  $517,400  was  issued  without  detachable
warrants.  The excess conversion value versus allocated proceeds was $2,216,864.
The proceeds of $517,400 were allocated to the beneficial conversion feature and
recorded in paid in capital in the consolidated balance sheet.

Convertible debt in the amount of $444,000 was issued with detachable  warrants.
The excess  conversion  value  versus  allocated  proceeds  was  $1,684,495.  In
accordance  with  Issue  98-5  model,  the  Company   calculated  the  estimated
conversion options.  (The calculation is attached to this response letter).  The
intrinsic  value of the  conversion  warrants  of $235,545  is  recognized  as a
reduction to the carrying amount of the convertible debt and an addition to paid
in capital.

The  balance  of the  proceeds  of  $208,000  was  allocated  to the  beneficial
conversion  feature and recorded in paid in capital in the consolidated  balance
sheet.

In  accordance  with APB 21,  the  Company  used  the  interest  method  for the
amortization  period of the beneficial  conversion  feature over the life of the
convertible debt.

SEC COMMENT #5:  Please  provide a detailed  analysis of how you  evaluated  the
embedded  conversion  option of the 6% Convertible  Note,  related  warrants and
additional investment rights under EITF 00-19.

COMPANY  RESPONSE:  Attached  to  this  response  letter  is a  computation  and
evaluation  of the  embedded  conversion  option of the  notes  and the  related
warrants.  Under the  provision  of EITF  00-19,  the Company has the ability to
issue the required number of authorized shares to be settled upon the conversion
of the convertible  notes and detachable  warrants.  The Company has 100,000,000
shares authorized of which over 36,000,000 are currently outstanding. If all the
convertible notes and warrants, at December 31, 2004, were converted into common
shares the total shares  converted  would be 22,033,200.  The Company  therefore
would not be required to classify  the  convertible  debt as a liability  as the
Company is in control of the settlement of shares. As of September 30, 2005, the
outstanding  convertible  notes and warrants were  convertible  into  17,683,200
common shares.

SEC COMMENT #6:  Please  explain to us and quantify the effect that would result
from your  revision of your  financial  statements  and why you have not filed a
Form 8-K regarding this error.

COMPANY  RESPONSE:  The  quantification  of the  effect of the  revision  of the
financial statement is as follows:

On July 21, 2005, the Company's  board of directors  concluded that, upon advice
from its independent auditor, the consolidated financial statements for the year
ended  December  31,  2004,  as issued in the  Company's  annual  report on Form
10-KSB, and the unaudited consolidated financial statements for the three months
ended March 31, 2005, as issued in its quarterly report on Form 10-QSB, required
restatement  because of an error in the calculation of allocation of proceeds to
warrants and the beneficial  conversion  feature of convertible  debt. The error
was  corrected  by  allocating  the  proceeds  to the  warrants  and  beneficial
conversion  feature of convertible  debt; and not to convertible debt. There was
also an adjustment to the valuation of the issued warrants.


The Company has  subsequently  filed a Form 8-K  reporting  the  revision of its
consolidated  financial  statements with respect to the  reclassification of its
convertible  debt as described in the preceding  paragraph,  which form included
the following tables as exhibits.


The  following  table shows the effect of the  restatement  of the  consolidated
Statements of Operations for the year ended December 31, 2004.

                                                         Year Ended
                                                      December 31, 2004
                                               --------------------------------
                                                  Original
                                                   Filing           Restated
                                               --------------    --------------
Revenue                                        $           --    $           --

Costs and expenses:
    General and administrative                      1,848,078         1,848,078
    Compensatory element of warrants                2,112,500                --
                                               --------------    --------------
                                                    3,960,578         1,848,078

    Loss from operations                           (3,960,578)       (1,848,078)
    Accretion of convertible debt                          --          (142,200)
    Writedown/loss for joint ventures                 (33,799)          (33,799)
    Interest expense                                  (27,966)          (27,966)
                                               --------------    --------------

    Loss before minority interest and
      benefit from income taxes                    (4,022,343)       (2,052,043)
    Minority interest share of loss of
      consolidated subsidiaries                       101,644           101,644
                                               --------------    --------------
    Loss before benefit from income taxes          (3,920,699)       (1,950,399)
    Benefit from income taxes                              --                --
                                               --------------    --------------

    Net loss                                   $   (3,920,699)   $   (1,950,399)
                                               ==============    ==============

    Loss per common share -
      basic and diluted                        $        (0.28)   $        (0.14)
                                               ==============    ==============

    Weighted average number of
      common shares outstanding                    14,250,963        14,250,963
                                               ==============    ==============


The  following  table shows the effect of the  restatement  on the  consolidated
Balance Sheets as of December 31, 2004.

                                                      December 31, 2004
                                               --------------------------------
                                                  Original
                                                   Filing           Restated
                                               --------------    --------------
Total Assets                                   $      441,444    $      441,444
                                               ==============    ==============

Current liabilities                                   629,066           629,066
Long-term liabilities                                 891,400           142,200
Minority interest in
  consolidated subsidiaries                           183,160           183,160
Stockholders' Deficiency                           (1,262,182)         (512,982)
                                               --------------    --------------

Total Liabilities and
  Stockholders' Deficiency                     $      441,444    $      441,444
                                               ==============    ==============


The  following  table shows the effect of the  restatement  on the  consolidated
Statements of Cash Flows for the year ended December 31, 2004.

                                                         Year Ended
                                                      December 31, 2004
                                               --------------------------------
                                                  Original
                                                   Filing           Restated
                                               --------------    --------------
Cash flows from operating activities:
Net loss                                       $   (3,920,699)   $   (1,950,399)
Adjustments to reconcile net loss
    to net cash in operating activities:
    Depreciation and amortization                       2,137             2,137
    Non cash compensation                             528,215           528,215
    Compensating elements of
      warrant issue                                 2,112,500                --
    Accretion of convertible debt                          --           142,200
    Issuance of common stock awards                    52,000            52,000
    Bad debt                                           47,521            47,521
    Writedown/loss from joint ventures                 33,799            33,799
    Minority interest in losses of
      consolidated subsidiaries                      (101,644)         (101,644)
    Changes in operating assests and
      liabilities                                    (106,253)         (106,253)
                                               --------------    --------------

Net cash used in operating activities              (1,352,424)       (1,352,424)

Net cash used in investing activities                  (3,793)           (3,793)

Net cash provided by financing activities           1,455,940         1,455,940
                                               --------------    --------------

Net increase in cash                                   99,723            99,723

Cash - Beginning of period                             14,057            14,057
                                               --------------    --------------

Cash - End of period                           $      113,780    $      113,780
                                               ==============    ==============


SEC COMMENT #7: In light of the above error,  please tell us if your  certifying
officers  have  reconsidered  its  effect  on the  adequacy  of your  disclosure
controls  and  procedures  as of the end of the  periods  covered  by your Forms
10-QSB Form 10-KSB for the periods affected by the above transactions.

COMPANY  RESPONSE:  The  Company's  certifying  officers  believe the  Company's
disclosure  controls and procedures as of the end of the periods  covered in the
Company's  Form  10-QSB and Form  10-KSB for the  periods  affected by the above
transactions were adequate.  When the Company's  independent  auditors revisited
the topic of the imbedded  beneficial  conversion  option within the convertible
debt,  the Company's  Board  recognized  the error and took steps to correct and
restate the financial statements in a timely manner.

Should  there be any other  questions or  comments,  please  contact me at (215)
258-2800.

Sincerely,


/s/ Peter F. Russo

Peter F. Russo
President


Delta Mutual, Inc.
Attachment to Company Response to SEC Comments #4 and #5
Jan 27 2006



                                                   Quoted                                                   Excess
                                                 Stock Price                               Conversion     Allocation     Allocation
              Issuance      Face/    Conversion     or BS     Convertible    Conversion     Alloc Vs       Proceeds       Proceeds
                date      Proceeds      Price    Calculation  Into shares      Value        Proceeds       Bene Conv      Warrants
- ------------------------------------------------------------------------------------------------------------------------------------
                                                                                             
Convertible
Debt          05/12/04  $    129,160    $0.125     $ 0.52      1,033,280    $    537,306  $    408,146   $    129,160
              05/12/04  $    193,740    $0.125     $ 0.52      1,549,920    $    805,958  $    612,218   $    193,740
              07/01/04  $    157,000    $ 0.05     $ 0.40      3,140,000    $  1,256,000  $  1,099,000   $    157,000
              07/16/04  $     37,500    $ 0.05     $ 0.18        750,000    $    135,000  $     97,500   $     37,500
              09/20/04  $    331,500    $ 0.05     $ 0.19      6,630,000    $  1,235,400  $  1,083,247   $    152,153   $    179,347
              10/19/04  $     25,000    $ 0.05     $ 0.26        500,000    $    130,000  $    116,724   $     13,276   $     11,724
              11/02/04  $     12,500    $ 0.05     $ 0.25        250,000    $     62,500  $     56,245   $      6,255   $      6,245
              11/05/04  $     25,000    $ 0.05     $ 0.23        500,000    $    115,000  $    103,251   $     11,749   $     13,251
              11/26/04  $     50,000    $ 0.05     $ 0.35      1,000,000    $    350,000  $    324,979   $     25,021   $     24,979
                        ------------                                                      ------------   ------------   ------------
      Total             $    961,400                                                      $  3,901,309   $    725,855   $    235,545
- ------------------------------------------------------------------------------------------------------------------------------------
Warrants      09/20/04                             $ 0.25      6,630,000    $  1,456,200  =$331500*1456200/(1456200+1235400=2691600)
              10/19/04                             $ 0.26        500,000    $    114,800  =25000*114800/(114800+130000=244800)
              11/02/04                             $ 0.25        250,000    $     62,400  =12500*62400/(62400+62500)
              11/05/04                             $ 0.23        500,000    $    129,700  =25000*129700/(129700+115000=244700)
              11/26/04                             $ 0.35      1,000,000    $    349,400  =50000*349400/(349400+350000=699400)

                                                              24,233,200
- ------------------------------------------------------------------------------------------------------------------------------------